GL1X · GenesisL1 explorer

MolNFT v1 · #56489 · protein

Thrombin inhibition

2ZGX · Thrombin light chain: “Thrombin inhibition”. X-ray diffraction, 2 ligands (29U, NA), 1 pocket (best druggability 0.55). MolNFT v1 #56489 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2ZGX
Type
protein
Length
287 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin light chain; Thrombin heavy chain; Hirudin variant-1
EC
3.4.21.5
UniProt
P00734, P01050
Ligands
29U, NA
Pockets
1 · best druggability 0.55

Structure

x-ray diffraction · 3 distinct chains · 18% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LThrombin light chain (EC 3.4.21.5)protein2737% helix, 0% strandP00734
HThrombin heavy chain (EC 3.4.21.5)protein25015% helix, 36% strandP00734
IHirudin variant-1protein1030% helix, 0% strandP01050

Ligands and binding sites

  • 29U · 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide · ligand · chains H
  • NA · Sodium ion · metal · 2 copies · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12640.550.763829U

Interfaces

2 interfaces between chains.

  • L–H · 1078 Ų buried · 29 hydrogen bonds · protein-protein
  • H–I · 632 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 2ZGX · Thrombin Inhibition · the same entry in another collection · chain L against L, TM-score 1.00
  • P01050 · AlphaFold monomer V2.0 prediction for hirudin variant-1 (P01050) · a predicted model of the same protein · chain I against A, TM-score 0.61

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.